Generic, twice-daily minocycline versus branded, extended-release minocycline for acne: A retrospective comparison of treatment escalation - 14/12/17
Funding sources: Preeta Gupta received funding from The Ohio State University College of Medicine Medical Student Research Scholarship. |
|
Conflicts of interest: Dr Kaffenberger has received grant funding from the American Acne and Rosacea Society for an unrelated project as well as research funding from Xoma, XBiotech, Biogen, and Celgene for clinical trials and is on the advisory board for Castle Biosciences. The other authors declared no conflicts of interest. |
Vol 76 - N° 6
P. 1195-1197 - juin 2017 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?